Darifenacin Hydrobromide News

← Back to News Overview

---

Darifenacin Hydrobromide currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Darifenacin Hydrobromide with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Original indication: Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.
• Evidence level: L5
• Predicted indications (20):
  • overactive bladder (disease) (99.8%)
  • polycystic kidney disease 3 with or without polycystic liver disease (96.9%)
  • thoracic malformation (96.1%)
  • renal-hepatic-pancreatic dysplasia (96.1%)
  • Joubert syndrome with renal defect (95.8%)
  • low compliance bladder (95.7%)
  • adult familial nephronophthisis-spastic quadriparesia syndrome (95.5%)
  • karyomegalic interstitial nephritis (95.3%)
  • polycystic kidney disease (92.4%)
  • primary hereditary glaucoma (86.7%)
  • respiratory failure (86.4%)
  • tic disorder (84.3%)
  • communication disorder (83.6%)
  • hypotrichosis simplex of the scalp (83.1%)
  • developmental disorder of mental health (83.0%)
  • fetal nicotine spectrum disorder (82.3%)
  • stereotypic movement disorder (82.3%)
  • blepharospasm (82.2%)
  • parkinsonian disorder (82.1%)
  • bladder neck obstruction (81.9%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.